Ginger & Baker

Ginger and Baker is a food hub, market and event destination housed in the historic grain mill in the River District. Her
business celebrates community, history, creativity and pie. She is also currently interim CEO of Walgreens
Boots Alliance.

Ginger has a broad and diverse background helping companies navigate big change under heavy regulatory
conditions. During her tenure at Amylin, the company launched two first-in-class medicines for people with
diabetes, was listed on the Nasdaq 100 and was rated as one of the Top Ten places in the industry for scientists
to work. Under her leadership, Guidant launched the world’s leading stent platform, was listed in the Fortune
500, was recognized by Fortune Magazine as one of the BestCompanies to Work for in America, and was
included in Industry Week Magazine’s 100 Best Managed Companies in the World.

Ginger has received numerous awards and honors including being named as the Emerging Company Executive
of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and
named as the American Diabetes Association’s Woman of Valor award in 2006. She was included in Pharma
VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her
number 10 on a list of 40 most influential people in the industry in 2007. Ginger was the first woman CEO
named to the PhRMA Board and Executive Committee. In 2018, she was recognized by Women Inc. Magazine
as one of the Most Influential Corporate Directors and in 2020 was named to the EBW 100 List of Most
Influential Global Leaders Empowering Women Worldwide.

Ginger earned a BS in Agricultural Economics with honors from the University of Arkansas and holds an MBA
with distinction from Harvard University. She serves on the Boards of Directors for Walgreen Boots Alliance
and is the Chair of the Board of Directors of Clovis Oncology, Inc. She is the co-chair of the Scientific Council
for the Center for Women’s Health Research at the University of Colorado, Anschutz and on the Advisory
Board of the BioFrontiers Institute at the CU campus in Boulder.

Ginger is a former faculty member at the Arthur Rock Center for Entrepreneurship at the Harvard Business
School and a former consultant to first-time CEOs in the areas of leadership, strategy, board-effectiveness, and
organization building. Her business career spans multiple industries including agriculture, cosmetics,
investment banking, pharmaceuticals, medical-devices and biotech. She is the former President and CEO of
Amylin Pharmaceuticals, and the former Group Chairman, Office of the President of Guidant Corporation, a
global cardiovascular medical device company.